quinta-feira, janeiro 06, 2005

Crixivan não recomendado para mulheres grávidas

FDA 27.12.04

Crixivan (Indinavir) Label Revised -- Not Recommended for HIV-Infected Pregnant Patients

The Clinical Pharmacology section of the Crixivan (indinavir) label has been revised to include pharmacokinetic data from a study (PACTG 358) in HIV-infected pregnant women. Results from this study show substantially reduced indinavir concentrations in women at 30-32 weeks gestation compared to postpartum. Based on these data, the Precautions Section now states that indinavir is not recommended in HIV-infected pregnant patients.

Comments: Enviar um comentário

<< Home

This page is powered by Blogger. Isn't yours?

Enter your email address below to subscribe to Blog do GAT!

powered by Bloglet